AVITA Medical

AVITA Medical

RCEL· Manufacturing· Fiscal year ends in December

CEO pay in FY2024Stock -6.7% in FY2024

Cary Vance is the CEO of AVITA Medical and was paid $0 in FY2024 (Dec).

Pay$100 in the stock at the end of FY23 → $93
CEO pay is from each AVITA Medical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1James CorbettFY2024
  2. 2David O'TooleFY2024
  3. 3Nicole KelseyFY2024
  4. 4Cary VanceFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

AVITA Medical paid its 4 named executives $6.3M in total in FY2024 (Dec). CEO Cary Vance was paid $0 of that.

Name
James CorbettFormer Chief Executive Officer
David O'TooleChief Financial Officer
Nicole KelseyChief Legal and Compliance Officer, and Interim SVP, Human ResourcesNot disclosed
Cary VanceInterim Chief Executive OfficerNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for AVITA Medical. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board1

See all
  • Joseph WoodyDirector · -1 yr on the boardIndependentAudit, Human Capital and Compensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 22, 2026FY2025
Annual report10-KFeb 12, 2026FY2025
Proxy statementDEF 14AApr 22, 2025FY2024
Annual report10-KFeb 13, 2025FY2024
Proxy statementDEF 14AApr 23, 2024FY2023
Annual report10-KFeb 22, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data